Vertex Pharmaceuticals Incorporated (VRTX)
USD 447.5
(-4.63%)
USD 447.5
(-4.63%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 3.53 Billion | 4.12 Billion | 2.64 Billion | 3.25 Billion | 1.56 Billion | 1.27 Billion |
| Net Income | 3.61 Billion | 3.32 Billion | 2.34 Billion | 2.71 Billion | 1.17 Billion | 2.08 Billion |
| Depreciation & Amortization | 181.3 Million | 148.3 Million | 125.6 Million | 109.51 Million | 106.94 Million | 72.42 Million |
| Deferred income taxes | -536.5 Million | -275.9 Million | -154.6 Million | 277.34 Million | 167.38 Million | -1.51 Billion |
| Stock-based compensation | 581.2 Million | 491.3 Million | 441.4 Million | 429.5 Million | 360.48 Million | 325.04 Million |
| Change in working capital | -265.7 Million | 340.8 Million | -105.2 Million | -54.45 Million | -66.1 Million | 238.02 Million |
| Other non-cash items | -42.6 Million | 103.4 Million | -5.8 Million | -220 Million | -176.19 Million | 60.02 Million |
| Investing Cash Flow | -3.14 Billion | -321.1 Million | -340.9 Million | 99.38 Million | -1.23 Billion | -202.15 Million |
| Investments in PPE | -258.39 Million | -204.7 Million | -235 Million | -259.8 Million | -75.45 Million | -95.52 Million |
| Acquisitions | -6.1 Million | -295.9 Million | 76.99 Million | -418.24 Million | -1.15 Billion | - |
| Investment purchases | -3.81 Billion | -740.5 Million | -605.2 Million | -450.72 Million | -576.51 Million | -515.38 Million |
| Sales/Maturities of investments | 934.2 Million | 920 Million | 499.3 Million | 809.9 Million | 570.86 Million | 431.57 Million |
| Other Investing Activities | 6.1 Million | 179.5 Million | -76.99 Million | 418.24 Million | -5.7 Million | -22.82 Million |
| Financing Cash Flow | -562.2 Million | -67.7 Million | -1.47 Billion | -505.28 Million | 126.77 Million | -71.21 Million |
| Debt repayment | -44.9 Million | -85.5 Million | -47 Million | -42.27 Million | -39.18 Million | -33.38 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -427.6 Million | -172 Million | -1.56 Billion | -739.4 Million | -192.01 Million | -350.04 Million |
| Common Stock Issuance | 134.6 Million | 186.3 Million | 102 Million | 264.94 Million | 343.24 Million | 289.29 Million |
| Other Financing Activities | -224.3 Million | 3.5 Million | 130.3 Million | 276.4 Million | 24.77 Million | 43.75 Million |
| Accounts receivables | -84.1 Million | -358.6 Million | -274.7 Million | -223.44 Million | -225.58 Million | -108.15 Million |
| Accounts payables | 48.7 Million | 120.8 Million | 31.9 Million | 51.27 Million | -22.78 Million | 36.55 Million |
| Inventory | -322.9 Million | -136.4 Million | -92.8 Million | -132.01 Million | -64.04 Million | -31.96 Million |
| Other working capital | 92.6 Million | 715 Million | 230.4 Million | 249.72 Million | 246.31 Million | 341.58 Million |
| Cash at beginning of period | 10.51 Billion | 6.8 Billion | 5.98 Billion | 3.12 Billion | 2.65 Billion | 1.66 Billion |
| Cash at end of period | 10.37 Billion | 10.51 Billion | 6.8 Billion | 5.98 Billion | 3.12 Billion | 2.65 Billion |
| Capital Expenditure | -258.39 Million | -204.7 Million | -235 Million | -259.8 Million | -75.45 Million | -95.52 Million |
| Effect of forex changes on cash | 26.9 Million | -29.2 Million | -13.4 Million | 20.55 Million | 1.64 Million | -6.18 Million |
| Net cash flow / Change in cash | -139.7 Million | 3.71 Billion | 811.2 Million | 2.86 Billion | 462.42 Million | 990.72 Million |
| Free Cash Flow | 3.27 Billion | 3.92 Billion | 2.4 Billion | 2.99 Billion | 1.49 Billion | 1.17 Billion |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 1.04 Billion | -3.59 Billion | 1.09 Billion | 968.8 Million | 3.61 Billion | 1.03 Billion |
| Depreciation & Amortization | 53.2 Million | 54 Million | 53.5 Million | 59 Million | 181.3 Million | 42.1 Million |
| Deferred income taxes | -123.3 Million | -118.8 Million | -158.3 Million | -131 Million | -536.5 Million | -115.5 Million |
| Stock-based compensation | 184.6 Million | 154.2 Million | 191.9 Million | 208.6 Million | 581.2 Million | 130.9 Million |
| Change in working capital | 112.1 Million | -241.4 Million | 129.3 Million | -838.9 Million | -265.7 Million | 188.9 Million |
| Other non-cash items | 97.8 Million | 251.4 Million | 621.1 Million | -31.9 Million | -42.6 Million | -13.3 Million |
| Investing Cash Flow | -348 Million | -463.7 Million | -2.13 Billion | -886.5 Million | -3.14 Billion | -117.7 Million |
| Investments in PPE | 120 Million | -76.7 Million | -248.4 Million | -116.1 Million | -258.39 Million | -40.6 Million |
| Acquisitions | - | - | - | -55.9 Million | -6.1 Million | 1.1 Million |
| Investment purchases | -1.12 Billion | -1.55 Billion | -2.59 Billion | -1.01 Billion | -3.81 Billion | -408.3 Million |
| Sales/Maturities of investments | 1.11 Billion | 1.18 Billion | 710.5 Million | 218.1 Million | 934.2 Million | 331.2 Million |
| Other Investing Activities | -453.8 Million | -15 Million | -180 Million | 31 Million | 6.1 Million | -1.1 Million |
| Financing Cash Flow | -387.5 Million | -358.6 Million | -357.5 Million | -119.8 Million | -562.2 Million | -165 Million |
| Debt repayment | -5.4 Million | -13.7 Million | -13.2 Million | -12 Million | -44.9 Million | -11.3 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -307.7 Million | -320.3 Million | -131.19 Million | -149.5 Million | -427.6 Million | -170.2 Million |
| Common Stock Issuance | 8.4 Million | 55 Million | 16.9 Million | 46.4 Million | 134.6 Million | 15.4 Million |
| Other Financing Activities | -82.79 Million | -79.6 Million | -230 Million | -4.7 Million | -224.3 Million | 16.5 Million |
| Accounts receivables | -51.8 Million | 135.1 Million | -251.6 Million | 15.4 Million | -84.1 Million | -6.1 Million |
| Accounts payables | 66.1 Million | -25.1 Million | 100 Thousand | -31.8 Million | 48.7 Million | 9.2 Million |
| Inventory | -182.5 Million | -107.2 Million | -80.1 Million | -70 Million | -322.9 Million | -97.5 Million |
| Other working capital | -216.7 Million | -244.2 Million | 460.9 Million | -752.5 Million | 92.6 Million | 283.3 Million |
| Cash at beginning of period | 4.58 Billion | 9.15 Billion | 10.37 Billion | 11.11 Billion | 10.51 Billion | 10.15 Billion |
| Cash at end of period | 5.24 Billion | 4.58 Billion | 9.15 Billion | 10.37 Billion | 10.37 Billion | 11.11 Billion |
| Capital Expenditure | 120 Million | -76.7 Million | -248.4 Million | -116.1 Million | -258.39 Million | -40.6 Million |
| Effect of forex changes on cash | 22.8 Million | -2.5 Million | -15.6 Million | 27.4 Million | 26.9 Million | -22.5 Million |
| Net cash flow / Change in cash | 668 Million | -4.57 Billion | -1.21 Billion | -744.3 Million | -139.7 Million | 963.2 Million |
| Free Cash Flow | 1.48 Billion | -3.83 Billion | 1.05 Billion | 118.5 Million | 3.27 Billion | 1.22 Billion |
MANAKSIA
0180
SUVEN
FAAS
BLMIF
COUNCODOS